LataMed AI Corp. (OTC: LMED), a healthcare technology company focused on digital health and artificial intelligence solutions for Latin America, announced its participation in the Artificial Intelligence & Health Markets 2026 conference, scheduled for August 13-14, 2026, at Universidad Santa Maria in Caracas, Venezuela. The event will bring together students and faculty from systems engineering and healthcare disciplines, including pharmacy, dentistry, and laboratory sciences, to explore practical applications of AI and automation.
Dr. Kevin Rodan Levy, CEO, and Carlos Pena, CFO, will represent the company, addressing the evolving role of AI in healthcare, systems engineering, digital infrastructure, and professional decision-making. The presentation will focus on how AI-supported tools can aid in medical-data evaluation, clinical workflows, and operational efficiency, while emphasizing that these technologies are designed to augment, not replace, professional judgment.
The conference will also cover topics such as integrating AI into existing systems, responsible data use, privacy, information security, and operational risk management. LataMed AI intends to discuss its healthcare technology ecosystem, including CardioAI, PulmoAI, and NeuroAI, which are being developed to assist in cardiovascular, pulmonary, and neurological health information management, subject to regulatory approvals and commercial implementation.
Dr. Levy stated, "Artificial Intelligence & Health Markets 2026 provides an important opportunity to engage directly with students, educators, and future professionals who will help shape the responsible use of artificial intelligence in healthcare and systems engineering. Our objective is to share practical perspectives on how intelligent technologies can support professional decision-making, improve digital workflows, and contribute to the continued development of healthcare infrastructure in Latin America."
This engagement aligns with LataMed AI's strategy to foster education and collaboration, and to better understand the perspectives of emerging professionals. The company views this as a step toward responsible adoption of digital healthcare infrastructure in the region. However, participation does not imply endorsement by the university, nor does it guarantee future collaborations or financial benefits.
For more information, visit https://latamed.ai or review filings with the SEC at www.sec.gov.
